Applications of Modern Technology to Emerging Viral Infections and Vaccine Development (From Firepower in the Lab: Automation in the Fight Against Infectious Diseases and Terrorism, P 93-100, 2001, Tony J. Beugelsdijk, Scott P. Layne, et al., eds. -- See NCJ-193061)

• NCJ Number: 193066
• Author(s): Gary J. Nabel
• Date Published: 2001
• Length: 8 pages
• Sale Source: Joseph Henry Press
• Publication Format: Book Chapter
• Publication Type: Research Paper
• Language: English
• Country: United States of America

Annotation

In this chapter the application of advanced technologies and techniques is discussed in the prevention, detection and treatment of emerging viral infections.

Abstract

The world is continuously susceptible to emerging infectious agents as seen through the rapid spread of the HIV and Ebola viruses. It is critical that appropriate detection and surveillance be maintained to better understand the patterns of spread of different viral types and help contain the spread of both viruses. New and innovative techniques have been used involving DNA immunization to control infection. In addition, the use of information technologies is necessary in understanding the mechanisms by which specific viral genes induce their characteristic immune responses by using various vaccine strategies and developing algorithms for prediction. In relation to treatment, genetic recombinant techniques provide the opportunity for more rapid development of antiviral treatment for human infectious disease. Molecular genetics, information technologies, and bioengineering are seen as significantly improving efforts to prevent, detect, and treat infectious diseases. Also, improved technologies for data collection, molecular analysis, and recombinant genetics aid in the ability to contain infectious outbreaks, occurring naturally and intentionally. The implementation of cost-effective, rapid, high-throughput screening technology allows for more expedient and effective responses to emerging infectious threats. References